Press kit: everything you need to cite us.
Journalists, researchers, and content publishers: bios, photos, statistics, and quote requests. Same-day response on deadline requests received before noon ET.
Press contact
On deadline?
press@glpzoom.comSame-day response before noon ET. Otherwise within 2 business days.
About GLPZoom
GLPZoom is an independent editorial and affiliate comparison platform for US telehealth programs covering GLP-1 weight management, ED, hair loss, mental health, and skincare treatments. We do not prescribe or dispense medications. Editorial rankings are never influenced by affiliate revenue. Affiliate relationships are disclosed inline on every page that includes them and aggregated on our affiliate disclosure.
Quick facts
36+
long-form articles
79+
Q&A entries
900+
state coverage pages
12
decision-support tools
17
clinical summaries
100%
primary-source cited
Editorial standards
- Primary sources only. Clinical claims sourced from FDA labels, peer-reviewed trials (PMID-cited), and specialty-society guidelines.
- "Last verified" dates. Every clinical page shows a verification date and a published correction log.
- Affiliate transparency. Affiliate links are disclosed inline. Editorial picks cannot be purchased.
- No fabricated reviewers. Pages display real reviewer credentials when available; otherwise organization-level editorial attribution is used.
Topics we comment on
GLP-1 medications
- · Wegovy
- · Ozempic
- · Zepbound
- · Mounjaro
- · Saxenda
- · Retatrutide
- · Orforglipron
Telehealth platforms
- · Ro
- · Hims
- · Sequence
- · Calibrate
- · NovoCare
- · LillyDirect
Regulatory + access
- · Insurance coverage patterns
- · Compounded GLP-1 legality
- · FDA decision calendar
- · State prescribing legality
- · Prior authorization timelines
Embed-ready statistics
Aggregated data we have compiled, free to cite with attribution to glpzoom.com:
- · Compounded GLP-1 pricing benchmarks across pharmacies and platforms
- · State-level telehealth GLP-1 prescribing legality (current verified date)
- · Insurance carrier formulary coverage patterns for Wegovy and Zepbound
- · Average prior-authorization approval timelines by carrier
Reviewer panel
We do not list reviewers we have not verified. As clinician reviewers are onboarded, their credentials, photos, and review areas will appear at /about/reviewers. Our editorial integrity rule: no fabricated reviewer names ever.
Brand assets
Logo files (SVG and PNG), color tokens, and editorial photography available on request. Email press@glpzoom.com with publication and use case.
See also: Newsroom · Research + datasets · Editorial policy · Methodology · Corrections